/PRNewswire/ NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in.
/PRNewswire/ BrickBio, the leader in RNA facilitated site-specific conjugation for novel protein therapeutics, will be presenting an invited poster at the.
/PRNewswire/ BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation chemistry, eCLIC™ that will complement its.
/PRNewswire/ BrickBio, the leader in site specific bioconjugation has launched a collaboration SiteSelect™ Panel for pharmaceutical and drug development.